CoChat

Relapse of Type A -Lactamase-Producing Staphylococcus aureus Native Valve Endocarditis during Cefazolin Therapy: Revisiting the Issue

Nannini, E. C., Singh, K. V., Murray, B. E. · 2003 · Clinical Infectious Diseases

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Our experience with a patient with methicillin-susceptible Staphylococcus aureus aortic native valve endocarditis, who had a relapse involving fever and positive blood culture results while receiving cefazolin, led us to evaluate this organism's ability to hydrolyze cefazolin at high inocula, a previously well-documented phenomenon. Analysis of the infecting strain disclosed a high minimum inhibitory concentration of cefazolin when a large inoculum was used, as well as rapid and complete cefazolin degradation, which was associated with regrowth in a time-kill experiment. DNA sequencing of the beta-lactamase gene showed that it was identical to that of the S. aureus type A beta-lactamase, known to efficiently inactivate cefazolin. A word of caution is given regarding the use of this antibiotic for treatment of endocarditis caused by this type of S. aureus isolate.

Overview

Integrity signals

Registry

Crossref · 10.1086/379021

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Cited by

See all 103

Metadata

Authors
Nannini, E. C., Singh, K. V., & Murray, B. E.
Affiliations
The University of Texas Health Science Center at Houston (US)
Corresponding author
Murray, B. E.
Venue
Clinical Infectious Diseases
Published
2003-11-01
Volume
37
Issue
9
Pages
1194-1198
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2137030105
Cited by
103
References
26
Citations by year
2026: 4 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 4 · 2016: 7 · 2015: 8 · 2014: 8 · 2013: 3 · 2012: 3
FWCI
2.81
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Keywords
Staphylococcus aureus, native valve endocarditis, aortic valve endocarditis, cefazolin, beta-lactamase, antibiotic resistance, minimum inhibitory concentration, time-kill kinetics, beta-lactamase genes, antibiotic treatment failure
MeSH terms
Anti-Bacterial Agents, beta-Lactamases, Cefazolin, Endocarditis, Bacterial, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Recurrence, Staphylococcal Infections, Staphylococcus aureus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.